The effect of intrauterine human chorionic gonadotropin injection on pregnancy outcomes in infertile patients
Phase 3
- Conditions
- Infertility.Complications of attempted introduction of embryo in embryo transfeN98.3
- Registration Number
- IRCT2012091310328N3
- Lead Sponsor
- Vise Canceler of Shahid Sadoughi University of Medical Sciences of Yazd, Research and Clinical Cente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 159
Inclusion Criteria
female
age in the range of 20-40 years
male factor infertility
unexplained infertility
basal FSH less than 12.
Exclusion Criteria
azoospermia,
presence of uterine myoma
endometriosis
hydrosalpinges
previous IVF/ICSI trials (successful or unsuccessful)
history of endocrine diseases such as diabetes and thyroid dysfunction
previous history of hysterocopic operation due to submoucosal myoma, and intrauterine synechia.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Implantation rate. Timepoint: Identified through vaginal or abdominal ultrasound 4-5 wks after the embryo transfer. Method of measurement: Observation of number of gestational sacs by transvaginal ultrasonography per 100 embryo transfer.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: BHCG test.;Clinical pregnancy. Timepoint: 4 -5 weeks after embryo transfer. Method of measurement: observation of fetal heart activity by trans vaginal or abdominal ultrasound.
- Secondary Outcome Measures
Name Time Method Abortion. Timepoint: Before the 20th week of pregnancy. Method of measurement: Abortion product observation (placenta and fetus residual).